The episode of the Life Sciences, AI Exchange features Hans Van Leeuwen (a regulatory consultant at ArisGlobal) and Ian Crone (Head of Regulatory Strategy and Growth at ArisGlobal) discussing how regulatory affairs (RA) is changing as pharma moves from document-based submissions to structured data. They note that companies still lack a true "single source of truth," relying on fragmented systems, manual handoffs, Excel trackers, and costly reconciliation that can create duplication, inconsistencies, and errors—pressures intensified by faster development and accelerated reviews post-COVID. They argue structured regulatory data (including IDMP) improves standardization, data quality, and internal communication, while enabling earlier detection of discrepancies as agencies increasingly use AI/ML to analyze submissions. They propose RA evolve from a submission-focused function to a product-data steward leading master data governance, API-enabled integrations, and unified RIM approaches, with structured master data hubs helping speed time to market and reduce delays. 00:00 Podcast Overview 00:38 Meet the Hosts 01:10 Data Everywhere in Pharma 02:37 No Single Source of Truth 04:51 Shift to Structured Submissions 07:06 IDMP as a Data Standard 09:08 RA as Data Steward 10:51 Culture Shift and AI Fears 12:30 Future RA in Development 15:16 Master Data Strategy and RIM 17:15 Wrap Up and Thanks